Off-label use of drugs in psychiatry and neurology;"Off-label use" in psychiatrie und neurologie

Fortschritte der Neurologie Psychiatrie

Volumn 72, Issue 5, 2004, Pages 243-244

  Wallesch, C W ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE;

DRUG INDICATION; DRUG USE; EDITORIAL; GERIATRICS; HEALTH CARE QUALITY; HUMAN; MEDICAL PRACTICE; MYASTHENIA; NEONATOLOGY; NEUROLOGY; OFF LABEL DRUG USE; PEDIATRICS; PSYCHIATRY; QUALITY CONTROL;

DRUG APPROVAL; GERMANY; HUMANS; MENTAL DISORDERS; NERVOUS SYSTEM DISEASES; PRACTICE GUIDELINES; PSYCHOTROPIC DRUGS;

EID: 2542466630     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-812452     Document Type: Editorial

References (2)

1. Wetterling T. Rechtsprechung zur Verabreichung von Medikamenten außerhalb der zugelassenen Indikationsgebiete ("off-label-use"). Fortschr. Neurol Psychiat 2004; 72: 255-259
2. Wetterling T. Verabreichung von Medikamenten außerhalb der zugelassenen Indikationsgebiete ("off-label-use"). Fortschr Neurol Psychiat 2004; 72: 245-254